Skip to main content

Advertisement

SpringerLink
Log in

Role of Speckle Tracking Echocardiography in the Evaluation of Breast Cancer Patients Undergoing Chemotherapy: Review and Meta-analysis of the Literature

  • Published:
Cardiovascular Toxicology Aims and scope Submit manuscript

Abstract

Diagnosis and management of Cancer therapeutics-related cardiac dysfunction is of crucial importance in breast cancer (BC) patients. The role of advanced echocardiographic techniques, such as deformation imaging, in the diagnosis and characterization of patients receiving cancer therapy has so far involved relatively small studies in the research setting. Therefore, we conducted a meta-analysis and systematic review of observational studies evaluating myocardial changes during chemotherapy detected through conventional echocardiographic parameters, such as 2D left ventricular ejection fraction (2D LVEF), and 2D Speckle tracking echocardiography (STE). The literature search retrieved 487 research works, articles, of which 17 were found to be pertinent with this topic. After full article review, 16 studies were considered suitable for the present analysis. Two separate analyses, one for the anthracyclines-based therapeutic regimen and one for the trastuzumab based therapeutic regimen, were performed. A significant reduction in 2D LVEF and 2D STE parameters during cancer therapy was found in both the investigations. Peak systolic global longitudinal strain demonstrated to be the most consistent 2D STE parameter in detecting early myocardial changes among all the studies. Thus, we confirmed the role of 2D STE for the early detection of myocardial damage, suggesting its crucial role in monitoring BC patients and eventually driving the introduction of cardioprotective treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sant, M., Allemani, C., Santaquilani, M., Knijn, A., Marchesi, F., Capocaccia, R., et al. (2009). EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. European Journal of Cancer, 45(6), 931–991. https://doi.org/10.1016/j.ejca.2008.11.018.

    Article  PubMed  Google Scholar 

  2. Bird, B. R., & Swain, S. M. (2008). Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems. Clinical Cancer Research, 14(1), 14–24. https://doi.org/10.1158/1078-0432.CCR-07-1033.

    Article  CAS  PubMed  Google Scholar 

  3. Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., et al. (2016). Cancer treatment and survivorship statistics. CA: A Cancer Journal for Clinicians, 66(4), 271–289. https://doi.org/10.3322/caac.21349.

    Article  Google Scholar 

  4. Jensen, B. V., Skovsgaard, T., & Nielsen, S. L. (2002). Functional monitoring of anthracycline cardiotoxicity: A prospective, blinded, long-term observational study of outcome in 120 patients. Annals of Oncology, 13(5), 699–709.

    Article  CAS  Google Scholar 

  5. Stokke, T. M., Hasselberg, N. E., Smedsrud, M. K., Sarvari, S. I., Haugaa, K. H., Smiseth, O. A., et al. (2017). Geometry as a confounder when assessing ventricular systolic function: Comparison between ejection fraction and strain. Journal of the American College of Cardiology, 70(8), 942–954. https://doi.org/10.1016/j.jacc.2017.06.046.

    Article  PubMed  Google Scholar 

  6. Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Cohen, V., et al. (2011). Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. The American Journal of Cardiology, 107(9), 1375–1380. https://doi.org/10.1016/j.amjcard.2011.01.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Thavendiranathan, P., Poulin, F., Lim, K. D., Plana, J. C., Woo, A., & Marwick, T. H. (2014). Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: A systematic review. Journal of the American College of Cardiology, 63(25 Pt A), 2751–2768. https://doi.org/10.1016/j.jacc.2014.01.073.

    Article  PubMed  Google Scholar 

  8. Boyd, A., Stoodley, P., Richards, D., Hui, R., Harnett, P., Vo, K., et al. (2017). Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study. PLoS ONE, 12(4), e0175544. https://doi.org/10.1371/journal.pone.0175544.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cadeddu, C., Piras, A., Dessi, M., Madeddu, C., Mantovani, G., Scartozzi, M., et al. (2017). Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy. The International Journal of Cardiovascular Imaging, 33(2), 197–207. https://doi.org/10.1007/s10554-016-0987-9.

    Article  PubMed  Google Scholar 

  10. Cheng, K. H., Handschumacher, M. D., Assuncao, B., Sebag, I. A., Halpern, E. F., & Scherrer-Crosbie, M. (2017). Contraction timing patterns in patients treated for breast cancer before and after anthracyclines therapy. Journal of the American Society of Echocardiography, 30(5), 454–460. https://doi.org/10.1016/j.echo.2016.12.013.

    Article  PubMed  Google Scholar 

  11. Dogru, A., Cabuk, D., Sahin, T., Dolasik, I., Temiz, S., & Uygun, K. (2013). Evaluation of cardiotoxicity via speckle-tracking echocardiography in patients treated with anthracyclines. Onkologie, 36(12), 712–716. https://doi.org/10.1159/000356850.

    Article  CAS  PubMed  Google Scholar 

  12. Fallah-Rad, N., Walker, J. R., Wassef, A., Lytwyn, M., Bohonis, S., Fang, T., et al. (2011). The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. Journal of the American College of Cardiology, 57(22), 2263–2270. https://doi.org/10.1016/j.jacc.2010.11.063.

    Article  CAS  PubMed  Google Scholar 

  13. Fei, H. W., Ali, M. T., Tan, T. C., Cheng, K. H., Salama, L., Hua, L., et al. (2016). Left ventricular global longitudinal strain in HER-2 + breast cancer patients treated with anthracyclines and trastuzumab who develop cardiotoxicity is associated with subsequent recovery of left ventricular ejection fraction. Echocardiography, 33(4), 519–526. https://doi.org/10.1111/echo.13168.

    Article  PubMed  Google Scholar 

  14. Florescu, M., Magda, L. S., Enescu, O. A., Jinga, D., & Vinereanu, D. (2014). Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer. Journal of the American Society of Echocardiography, 27(1), 83–92. https://doi.org/10.1016/j.echo.2013.10.008.

    Article  PubMed  Google Scholar 

  15. Hare, J. L., Brown, J. K., Leano, R., Jenkins, C., Woodward, N., & Marwick, T. H. (2009). Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. American Heart Journal, 158(2), 294–301. https://doi.org/10.1016/j.ahj.2009.05.031.

    Article  CAS  PubMed  Google Scholar 

  16. Lange, S. A., Jung, J., Jaeck, A., Hitschold, T., & Ebner, B. (2016). Subclinical myocardial impairment occurred in septal and anterior LV wall segments after anthracycline-embedded chemotherapy and did not worsen during adjuvant trastuzumab treatment in breast cancer patients. Cardiovascular Toxicology, 16(2), 193–206. https://doi.org/10.1007/s12012-015-9328-9.

    Article  CAS  PubMed  Google Scholar 

  17. Mele, D., Malagutti, P., Indelli, M., Ferrari, L., Casadei, F., Da Ros, L., et al. (2016). Reversibility of left ventricle longitudinal strain alterations induced by adjuvant therapy in early breast cancer patients. Ultrasound in Medicine and Biology, 42(1), 125–132. https://doi.org/10.1016/j.ultrasmedbio.2015.09.008.

    Article  PubMed  Google Scholar 

  18. Negishi, K., Negishi, T., Hare, J. L., Haluska, B. A., Plana, J. C., & Marwick, T. H. (2013). Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. Journal of the American Society of Echocardiography, 26(5), 493–498. https://doi.org/10.1016/j.echo.2013.02.008.

    Article  PubMed  Google Scholar 

  19. Santoro, C., Arpino, G., Esposito, R., Lembo, M., Paciolla, I., Cardalesi, C., et al. (2017). 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: A balance with feasibility. European Heart Journal-Cardiovascular Imaging, 18(8), 930–936. https://doi.org/10.1093/ehjci/jex033.

    Article  PubMed  Google Scholar 

  20. Stoodley, P. W., Richards, D. A., Boyd, A., Hui, R., Harnett, P. R., Meikle, S. R., et al. (2013). Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: A comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months. European Journal of Cancer, 49(16), 3396–3403. https://doi.org/10.1016/j.ejca.2013.06.046.

    Article  CAS  PubMed  Google Scholar 

  21. Stoodley, P. W., Richards, D. A., Hui, R., Boyd, A., Harnett, P. R., Meikle, S. R., et al. (2011). Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. European Journal of Echocardiography, 12(12), 945–952. https://doi.org/10.1093/ejechocard/jer187.

    Article  PubMed  Google Scholar 

  22. Tang, Q., Jiang, Y., Xu, Y., & Xia, H. (2017). Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer. Journal of Clinical Ultrasound, 45(4), 222–230. https://doi.org/10.1002/jcu.22434.

    Article  PubMed  Google Scholar 

  23. Toufan, M., Pourafkari, L., Ghahremani Nasab, L., Esfahani, A., Sanaat, Z., Nikanfar, A., et al. (2017). Two-dimensional strain echocardiography for detection of cardiotoxicity in breast cancer patients undergoing chemotherapy. Journal of Cardiovascular and Thoracic Research, 9(1), 29–34. https://doi.org/10.15171/jcvtr.2017.04.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Sawaya, H., Sebag, I. A., Plana, J. C., Januzzi, J. L., Ky, B., Tan, T. C., et al. (2012). Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circulation: Cardiovascular Imaging, 5(5), 596–603. https://doi.org/10.1161/CIRCIMAGING.112.973321.

    Article  Google Scholar 

  25. Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., et al. (2015). Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation, 131(22), 1981–1988. https://doi.org/10.1161/CIRCULATIONAHA.114.013777.

    Article  CAS  Google Scholar 

  26. Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., et al. (2011). Adjuvant trastuzumab in HER2-positive breast cancer. The New England Journal of Medicine, 365(14), 1273–1283.

    Article  CAS  Google Scholar 

  27. Thavendiranathan, P., Grant, A. D., Negishi, T., Plana, J. C., Popovic, Z. B., & Marwick, T. H. (2013). Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: Application to patients undergoing cancer chemotherapy. Journal of the American College of Cardiology, 61(1), 77–84. https://doi.org/10.1016/j.jacc.2012.09.035.

    Article  PubMed  Google Scholar 

  28. Farsalinos, K. E., Daraban, A. M., Unlu, S., Thomas, J. D., Badano, L. P., & Voigt, J. U. (2015). Head-to-head comparison of global longitudinal strain measurements among nine different vendors: The EACVI/ASE inter-vendor comparison study. Journal of the American Society of Echocardiography, 28(10), 1171–1181. https://doi.org/10.1016/j.echo.2015.06.011.

    Article  PubMed  Google Scholar 

  29. Potter, E., & Marwick, T. H. (2018). Assessment of left ventricular function by echocardiography: The case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovascular Imaging, 11(2 Pt 1), 260–274. https://doi.org/10.1016/j.jcmg.2017.11.017.

    Article  PubMed  Google Scholar 

  30. Sarvari, S. I., Haugaa, K. H., Zahid, W., Bendz, B., Aakhus, S., Aaberge, L., et al. (2013). Layer-specific quantification of myocardial deformation by strain echocardiography may reveal significant CAD in patients with non-ST-segment elevation acute coronary syndrome. JACC Cardiovascular Imaging, 6(5), 535–544. https://doi.org/10.1016/j.jcmg.2013.01.009.

    Article  PubMed  Google Scholar 

  31. Smiseth, O. A., Torp, H., Opdahl, A., Haugaa, K. H., & Urheim, S. (2016). Myocardial strain imaging: how useful is it in clinical decision making? European Heart Journal, 37(15), 1196–1207. https://doi.org/10.1093/eurheartj/ehv529.

    Article  PubMed  Google Scholar 

  32. Geyer, H., Caracciolo, G., Abe, H., Wilansky, S., Carerj, S., Gentile, F., et al. (2010). Assessment of myocardial mechanics using speckle tracking echocardiography: Fundamentals and clinical applications. Journal of the American Society of Echocardiography, 23(4), 351–369. https://doi.org/10.1016/j.echo.2010.02.015. quiz 453–355.

    Article  PubMed  Google Scholar 

  33. Mor-Avi, V., Lang, R. M., Badano, L. P., Belohlavek, M., Cardim, N. M., Derumeaux, G., et al. (2011). Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. European Journal of Echocardiography, 12(3), 167–205. https://doi.org/10.1093/ejechocard/jer021.

    Article  PubMed  Google Scholar 

  34. Ng, A. C., Delgado, V., Bertini, M., Antoni, M. L., van Bommel, R. J., van Rijnsoever, E. P., et al. (2011). Alterations in multidirectional myocardial functions in patients with aortic stenosis and preserved ejection fraction: A two-dimensional speckle tracking analysis. European Heart Journal, 32(12), 1542–1550. https://doi.org/10.1093/eurheartj/ehr084.

    Article  PubMed  Google Scholar 

  35. Ho, E., Brown, A., Barrett, P., Morgan, R. B., King, G., Kennedy, M. J., et al. (2010). Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: A speckle tracking echocardiographic study. Heart, 96(9), 701–707. https://doi.org/10.1136/hrt.2009.173997.

    Article  CAS  PubMed  Google Scholar 

  36. Rosen, B. D., Edvardsen, T., Lai, S., Castillo, E., Pan, L., Jerosch-Herold, M., et al. (2005). Left ventricular concentric remodeling is associated with decreased global and regional systolic function: The Multi-Ethnic Study of Atherosclerosis. Circulation, 112(7), 984–991. https://doi.org/10.1161/CIRCULATIONAHA104.500488.

    Article  PubMed  Google Scholar 

  37. Perel, R. D., Slaughter, R. E., & Strugnell, W. E. (2006). Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing’s sarcoma. Journal of Cardiovascular Magnetic Resonance, 8(6), 789–791. https://doi.org/10.1080/10976640600737664.

    Article  PubMed  Google Scholar 

  38. Zamorano, J. L., Lancellotti, P., Rodriguez Munoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., et al. (2017). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). European Heart Journal, 19(1), 9–42. https://doi.org/10.1002/ejhf.654.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Medicine, University of Verona, P.le Stefani 1, 37126, Verona, Italy

    Corinna Bergamini, Giulia Dolci, Stella Truong, Luisa Zanolla, Giovanni Benfari, Andrea Rossi & Flavio Luciano Ribichini

  2. Division of Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy

    Elena Fiorio

Authors
  1. Corinna Bergamini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giulia Dolci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stella Truong
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luisa Zanolla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanni Benfari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elena Fiorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrea Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Flavio Luciano Ribichini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Corinna Bergamini.

Ethics declarations

Conflict of interest

Drs. Corinna Bergamini, Giulia Dolci, Stella Truong, Luisa Zanolla, Giovanni Benfari, Elena Fiorio, Andrea Rossi and Flavio Luciano Ribichini have no conflicts of interest or financial ties to disclose.

Additional information

Handling Editor: Martin Štěrba.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 45 kb)

Supplementary material 2 (DOCX 59 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bergamini, C., Dolci, G., Truong, S. et al. Role of Speckle Tracking Echocardiography in the Evaluation of Breast Cancer Patients Undergoing Chemotherapy: Review and Meta-analysis of the Literature. Cardiovasc Toxicol 19, 485–492 (2019). https://doi.org/10.1007/s12012-019-09523-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12012-019-09523-y

Keywords

Search

Navigation